BLOC1S5-TXNDC5

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, BLOC1S5-TXNDC5 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated BLOC1S5-TXNDC5 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher BLOC1S5-TXNDC5 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated BLOC1S5-TXNDC5 expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.

KIRP, COAD, and UCEC are the cancer types where BLOC1S5-TXNDC5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRPDFSMedianAll0.3100.871<.00114view →
COADOSMedianIII,IV0.2520.696.01712view →
UCECDFSMedianAll0.9430.616.0136view →
SKCMDFSMedianII,III,IV0.9110.559.0264view →
LUADDFSMedianAll1.0000.657.0302view →
Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

BLOC1S5-TXNDC5–KIRP (DFS)

Kaplan–Meier survival curve for BLOC1S5-TXNDC5 mutant vs wild-type samples in KIRP.

Open the KIRP breakdown →

Exploration